Found 12 matching trials
Tolerability and Efficacy of Intravenous Infusion of Autologous MSC_Apceth for the Treatment of Critical Limb Ischemia
PHASE1MSC\_Apceth are GMP-manufactured, autologous ex-vivo expanded non-hemapoiet...
Location
Isar Medizin Zentrum
Intravenous Autologous Mesenchymal Stem Cells Transplantation to Treat Middle Cerebral Artery Infarct
PHASE2This study aims to determine the efficacy of intravenous transplantation of...
Location
UKM Medical Centre
Study to Evaluate Hepatic Artery Injection of Autologous Human Bone Marrow-Derived MSCs in Patients With Alcoholic LC
PHASE1This study is to evaluate the safety and efficacy of a single dose of Cellg...
Location
University of Utah
Trial of Autologous Mesenchymal Stem Cells in Patients With Multiple System Atrophy
PHASE2This study is based on positive results in open label trial of mesenchymal ...
Location
Severance Hospital
MSC for Occlusive Disease of the Kidney
PHASE1To determine the safety and toxicity of intra-arterial infused autologous a...
Location
Mayo Clinic in Rochester
Autologous Bone Marrow Stromal Cell and Endothelial Progenitor Cell Transplantation in Ischemic Stroke
PHASE1The purpose of this study is to evaluate the feasibility, efficacy, and saf...
Location
Zhujiang Hospital, Southern Medical University
Clinical Trial to Evaluate Bone Marrow Stem Cell Therapy for PSP, a Rare Form of Parkinsonism
PHASE1There is evidence suggesting that stem cells harvested from the bone marrow...
Location
ICP Parkinson Institute
Patient-Derived Stem Cell Therapy for Diabetic Kidney Disease
PHASE1The Researchers will assess the safety, tolerability, dosing effect, and ea...
Location
Mayo Clinic in Rochester
Induction Therapy With Autologous Mesenchymal Stem Cells for Kidney Allografts
NAThe goal of this study is to evaluate autologous MSCs as an alternative for...
Location
Stem cell therapy center,Fuzhou General Hospital
Autologous Mesenchymal Stem Cell Transplantation in Cirrhosis Patients With Refractory Ascites
PHASE3Liver cirrhosis (LC) is the final destiny in chronic liver disease.The qual...